Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $1.79 billion. The enterprise value is $1.73 billion.

Market Cap	1.79B
Enterprise Value	1.73B

Important Dates

The next estimated earnings date is Monday, March 10, 2025, after market close.

Earnings Date	Mar 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Belite Bio has 30.88 million shares outstanding. The number of shares has increased by 15.58% in one year.

Current Share Class	n/a
Shares Outstanding	30.88M
Shares Change (YoY)	+15.58%
Shares Change (QoQ)	+1.20%
Owned by Insiders (%)	2.29%
Owned by Institutions (%)	0.48%
Float	28.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	16.21
P/TBV Ratio	16.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 30.73

Current Ratio	30.73
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,419.76

Financial Efficiency

Return on equity (ROE) is -40.04% and return on invested capital (ROIC) is -26.89%.

Return on Equity (ROE)	-40.04%
Return on Assets (ROA)	-25.58%
Return on Capital (ROIC)	-26.89%
Revenue Per Employee	n/a
Profits Per Employee	-$1.65M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Belite Bio has paid $5,000 in taxes.

Income Tax	5,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.02% in the last 52 weeks. The beta is -1.56, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.56
52-Week Price Change	+25.02%
50-Day Moving Average	66.43
200-Day Moving Average	53.30
Relative Strength Index (RSI)	43.73
Average Volume (20 Days)	43,226

Short Selling Information

Short Interest	80,387
Short Previous Month	202,318
Short % of Shares Out	0.62%
Short % of Float	n/a
Short Ratio (days to cover)	1.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-35.49M
Pretax Income	-31.62M
Net Income	-33.03M
EBITDA	-35.30M
EBIT	-35.49M
Earnings Per Share (EPS)	-$1.11

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	112.20M
Book Value Per Share	3.63
Working Capital	107.65M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.58%
Shareholder Yield	-15.58%
Earnings Yield	-1.82%
FCF Yield	n/a

Analyst Forecast

The average price target for Belite Bio is $96.33, which is 65.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$96.33
Price Target Difference	65.80%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1